Scientists hunt for clues to personalize stomach cancer care
NCT ID NCT05508399
Summary
This study aimed to find biological markers that could predict which patients with a type of stomach cancer would respond best to a specific treatment combination. Researchers observed 28 patients who received immunotherapy plus chemotherapy before surgery. They analyzed patient samples to build a model that might one day help doctors choose the most effective treatment for each individual.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Xijing Hospital of Digestive Diseases
Xi'an, Shaanxi, 710000, China
Conditions
Explore the condition pages connected to this study.